Showing results (31-40 of 253) with videos related to
Sort By:
Pageof 26
Drugs|January 23, 2017
Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell MalignanciesKevin A Hay, Cameron J TurtleImmunology and Cell Biology|February 9, 2011
Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemiaMarie Bleakley, Stanley R RiddellTrends in Immunology|July 15, 2015
Engineering CAR-T cells: Design conceptsShivani Srivastava, Stanley R RiddellJournal of Immunology (Baltimore, Md. : 1950)|January 10, 2018
Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside EfficacyShivani Srivastava, Stanley R RiddellJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2017
Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of IbrutinibCameron J Turtle, Kevin A Hay, Laïla-Aïcha Hanafi, et al.CNS Drugs|November 3, 2018
Neurotoxicity Associated with CD19-Targeted CAR-T Cell TherapiesJuliane Gust, Agne Taraseviciute, Cameron J TurtleCurrent Opinion in Immunology|January 27, 2015
Designing chimeric antigen receptors to effectively and safely target tumorsMichael C Jensen, Stanley R RiddellImmunological Reviews|December 17, 2013
Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cellsMichael C Jensen, Stanley R RiddellCell|August 5, 2022
Immune checkpoint blockade provokes resident memory T cells to eliminate head and neck cancerJoshua R Veatch, Stanley R RiddellCancer Cell|April 12, 2022
Synthetic HLA-independent T cell receptors for cancer immunotherapySylvain Simon, Grace Bugos, Stanley R RiddellPageof 26